However, after excluding the poor genetic group, which included eight Ph-positive t (9;22) BCP-ALL patients, CD34 emerged as the most robust independent predictor, consistent with the findings of Modvig et al (54). The gene discussed is CD34; the disease is acute lymphoblastic leukemia.